Cargando…
Coagulation abnormalities in critically ill patients
Many critically ill patients develop hemostatic abnormalities, ranging from isolated thrombocytopenia or prolonged global clotting tests to complex defects, such as disseminated intravascular coagulation. There are many causes for a deranged coagulation in critically ill patients and each of these u...
Autores principales: | , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2006
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1750988/ https://www.ncbi.nlm.nih.gov/pubmed/16879728 http://dx.doi.org/10.1186/cc4975 |
_version_ | 1782131400615395328 |
---|---|
author | Levi, Marcel Opal, Steven M |
author_facet | Levi, Marcel Opal, Steven M |
author_sort | Levi, Marcel |
collection | PubMed |
description | Many critically ill patients develop hemostatic abnormalities, ranging from isolated thrombocytopenia or prolonged global clotting tests to complex defects, such as disseminated intravascular coagulation. There are many causes for a deranged coagulation in critically ill patients and each of these underlying disorders may require specific therapeutic or supportive management. In recent years, new insights into the pathogenesis and clinical management of many coagulation defects in critically ill patients have been accumulated and this knowledge is helpful in determining the optimal diagnostic and therapeutic strategy. |
format | Text |
id | pubmed-1750988 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2006 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-17509882006-12-27 Coagulation abnormalities in critically ill patients Levi, Marcel Opal, Steven M Crit Care Review Many critically ill patients develop hemostatic abnormalities, ranging from isolated thrombocytopenia or prolonged global clotting tests to complex defects, such as disseminated intravascular coagulation. There are many causes for a deranged coagulation in critically ill patients and each of these underlying disorders may require specific therapeutic or supportive management. In recent years, new insights into the pathogenesis and clinical management of many coagulation defects in critically ill patients have been accumulated and this knowledge is helpful in determining the optimal diagnostic and therapeutic strategy. BioMed Central 2006 2006-07-19 /pmc/articles/PMC1750988/ /pubmed/16879728 http://dx.doi.org/10.1186/cc4975 Text en Copyright © 2006 BioMed Central Ltd |
spellingShingle | Review Levi, Marcel Opal, Steven M Coagulation abnormalities in critically ill patients |
title | Coagulation abnormalities in critically ill patients |
title_full | Coagulation abnormalities in critically ill patients |
title_fullStr | Coagulation abnormalities in critically ill patients |
title_full_unstemmed | Coagulation abnormalities in critically ill patients |
title_short | Coagulation abnormalities in critically ill patients |
title_sort | coagulation abnormalities in critically ill patients |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1750988/ https://www.ncbi.nlm.nih.gov/pubmed/16879728 http://dx.doi.org/10.1186/cc4975 |
work_keys_str_mv | AT levimarcel coagulationabnormalitiesincriticallyillpatients AT opalstevenm coagulationabnormalitiesincriticallyillpatients |